Altimmune, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Jun 2016 | — | -214.8% | -216.8% |
| Sep 2016 | — | -531.6% | -532.2% |
| Mar 2017 | — | -1,507.8% | -1,528.4% |
| Jun 2017 | — | -132.0% | -102.4% |
| Sep 2017 | — | -674.1% | -651.3% |
| Dec 2017 | — | -447.3% | -314.4% |
| Mar 2018 | — | -222.8% | -117.9% |
| Jun 2018 | — | -224.9% | -378.1% |
| Sep 2018 | — | -154.0% | -89.2% |
| Dec 2018 | — | -1,056.4% | -946.7% |
| Mar 2019 | — | -78.8% | -71.0% |
| Jun 2019 | — | -218.4% | -208.3% |
| Sep 2019 | — | -1,750.6% | -1,698.7% |
| Dec 2019 | — | -748.9% | -711.5% |
| Mar 2020 | — | -330.2% | -175.6% |
| Jun 2020 | — | -2,552.3% | -2,323.5% |
| Sep 2020 | — | -623.7% | -604.8% |
| Dec 2020 | — | -464.8% | -459.3% |
| Mar 2021 | — | -1,773.4% | -1,773.7% |
| Jun 2021 | — | -18,148.9% | -18,121.9% |
| Sep 2021 | — | -21,015.2% | -21,208.9% |
| Dec 2021 | — | -731.9% | -729.0% |
| Mar 2022 | — | -60,934.4% | -60,718.8% |
| Jun 2022 | — | -254,937.5% | -251,337.5% |
| Sep 2022 | — | -1,237,600.0% | -1,175,800.0% |
| Dec 2022 | — | 20,994.5% | 19,690.9% |
| Mar 2023 | — | -103,614.3% | -95,590.5% |
| Jun 2023 | — | -300,116.7% | -267,683.3% |
| Sep 2023 | — | -6,226.5% | -5,710.2% |
| Dec 2023 | — | -90,873.0% | -85,516.2% |
| Mar 2024 | — | -535,880.0% | -487,880.0% |
| Jun 2024 | — | -534,900.0% | -492,800.0% |
| Sep 2024 | — | -495,340.0% | -456,900.0% |
| Dec 2024 | — | -497,320.0% | -463,600.0% |
| Mar 2025 | — | -436,300.0% | -391,500.0% |
| Jun 2025 | — | -458,440.0% | -442,920.0% |
| Sep 2025 | — | -417,180.0% | -380,280.0% |
| Dec 2025 | — | -111,126.9% | -105,223.1% |